Data Manager at Vor Bio

Boston, Massachusetts, United States

Vor Bio Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Bachelor's Degree in programming, health-related sciences, or relevant field
  • 5+ years of Data Management experience

Responsibilities

  • Ensure the CRO and other internal and external partners align and conform to data management expectations for the assigned compound and/or indication
  • Participate in the creation of the clinical development plan, describing the clinical development strategy and possible innovative trial designs
  • Set quality expectations and timelines for data management deliverables and regularly follow up on data management milestones. Ensure inspection readiness at all times
  • Set expectations and communicate in a transparent, clear way and motivate team members to work towards achieving the clinical goals
  • Follow department and company standard operating procedures (SOPs), forms, templates and policies. Provide feedback and update these guidelines as needed
  • Develop, review, and maintain all study Data Management documentation
  • Coordinate with Database Developers to ensure effective database build and timely go-live to meet the needs of the project
  • Ensure the clinical database adheres to Clinical Data Acquisition Standards Harmonization guidelines allowing for optimal SDTM dataset programming. Suggest design for standard and non-standard data collection, identify any gaps in data collection, and challenge collection of unnecessary data
  • Define electronic case report form (eCRF) and edit check specifications to support data collection and analysis required per protocol
  • Take responsibility for and guide effective quality control (QC) review and user acceptance testing (UAT) of the clinical database prior to its release into production, including oversight of staff performing these tasks
  • Ensure data are properly reviewed in accordance with the Data Management Plan (DMP) and guidelines and that cleaning is effective and timely
  • Provide input on study timelines, identify risks, and communicate mitigation strategies to the Project Manager
  • Provide input into improving the efficiency of data management tasks
  • Lead and participate in intradepartmental or interdepartmental process and quality improvement initiatives

Skills

Clinical Data Management
Database Lock
Data Archiving
CRO Oversight
Data Quality Assurance
Regulatory Compliance
Mentoring
Clinical Development Planning

Vor Bio

Develops targeted therapies for blood cancers

About Vor Bio

Vor Biopharma focuses on developing treatments for blood cancers, particularly Acute Myeloid Leukemia (AML). Their approach is designed to protect healthy cells while specifically targeting and eliminating cancerous cells. This method aims to improve the effectiveness of blood cancer treatments. Vor Biopharma serves patients with blood cancers, their caregivers, and medical professionals in hospitals and oncology centers. What sets Vor Biopharma apart from competitors is their strong emphasis on research and development, investing significantly in scientific research to create a proprietary platform and pipeline of therapies. They generate revenue through partnerships with other pharmaceutical companies and licensing agreements, with the goal of commercializing their therapies after obtaining regulatory approval. The company's mission is to transform the treatment landscape for blood cancers by providing innovative therapies that prioritize patient safety and efficacy.

Cambridge, MassachusettsHeadquarters
2015Year Founded
$147.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Vacation
Parental Leave
401(k) Retirement Plan
401(k) Company Match
Commuter Benefits

Risks

Significant YTD price decline of -62.76% may affect investor confidence.
Key clinical trial data updates are not expected until 2025, causing uncertainty.
Increased competition from companies like Editas Medicine poses potential conflicts.

Differentiation

Vor Bio focuses on protecting healthy cells while targeting cancerous ones.
The company specializes in innovative treatments for blood cancers like AML.
Vor Bio's approach aligns with the rise of personalized medicine.

Upsides

Recent $55.6M funding supports clinical trials and extends cash runway to 2025.
FDA's acceptance of gene therapies may ease approval for Vor Bio's treatments.
Advancements in CRISPR technology enhance precision of Vor Bio's gene editing.

Land your dream remote job 3x faster with AI